We’re thrilled to share a huge win for the DataBiologics community—a subset of our real-world outcomes data has been independently analyzed by one of the top academic institutions in the country.

A team of physicians and statisticians at NYU Langone Health conducted a retrospective analysis of PRP treatment data from our registry, and their findings were recently accepted by the American Academy of Pain Medicine.

🔍 What They Found:

• Patients with knee osteoarthritis who received PRP early in the disease course (Kellgren-Lawrence Grade I–II) showed significant improvements in pain and function at 6 and 12 months.
• These results were based on real-world patient-reported outcomes from 300 de-identified records in the DataBiologics registry.
• The study validates that early intervention is effective—and our registry is one of the first to demonstrate this on a national scale.

This is exactly the kind of impact we envisioned when building DataBiologics: empowering providers with real-world evidence and accelerating findings based on this evidence.

👉 Read the full summary here: www.databiologics.com/nyu-langone-prp-research

🕐 Less Than Two Weeks Left to Invest

As we enter the final stretch of our Wefunder campaign, this milestone couldn’t be more timely. It’s proof that the data we’re collecting is changing the way regenerative treatments are evaluated.

If you haven’t yet invested—or know someone who should—now’s the time. Help us bring this vision to more clinics, more partners, and more patients.